Clinical Trials in Banja Luka, Bosnia and Herzegovina
8 recruiting
Showing 1–9 of 9 trials
Recruiting
Not Applicable
Performance of the Cardiac Microcurrent (C-MIC) System With a Less Invasively Placed Left Ventricular Lead
Non-ischemic CardiomyopathyLeft Ventricular (LV) Systolic DysfunctionIdiopathic Cardiomyopathy
Berlin Heals GmbH22 enrolled4 locationsNCT06920030
Recruiting
Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Heart Failure
Novo Nordisk A/S5,600 enrolled1117 locationsNCT05636176
Recruiting
Phase 2
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
ColitisInflammatory Bowel DiseasesUlcerative Colitis+1 more
Spyre Therapeutics, Inc.645 enrolled126 locationsNCT07012395
Recruiting
Phase 3
Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis
Relapsing Multiple Sclerosis
Sandoz175 enrolled40 locationsNCT06847724
Recruiting
Phase 3
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis
TG Therapeutics, Inc.360 enrolled42 locationsNCT07211633
Recruiting
Phase 3
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Non-Hodgkin LymphomaBacterial InfectionsHypogammaglobulinemia+2 more
Grifols Therapeutics LLC386 enrolled61 locationsNCT05645107
Recruiting
Phase 1
A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.20 enrolled6 locationsNCT07130916
Recruiting
Phase 3
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Hepatocellular CarcinomaCirrhosis
Can-Fite BioPharma471 enrolled32 locationsNCT05201404
Recruiting
Phase 1
A Study of ZN-c3 in Patients With Ovarian Cancer
Solid TumorFallopian Tube CancerEpithelial Ovarian Cancer+1 more
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc140 enrolled24 locationsNCT04516447